Core Laboratories Inc. (CLB) revenue and earnings history
Core Laboratories Inc. reported revenue of $527M for fiscal 2025 (year ended Dec 31, 2025), +0.5% on the year before, and net income of $29.7M.
Over 4 years, from fiscal 2021 to fiscal 2025, revenue grew at a compound rate of +2.9% a year.
Revenue and net income, 5 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $527M+0.5% | $56.5M | $29.7M | $37M | $11.2M | $25.8M | $7.14M | $12.4M | $1.87M | $22.7M | $113M | 10-K |
| 2024 |
The latest quarter, insider trades and fund moves: Core Laboratories Inc. (CLB) on OQRO.
Common questions
What was Core Laboratories Inc.'s revenue in fiscal 2025?
$527M for the year ended Dec 31, 2025, as reported in its 10-K filed Mar 23, 2026. That is +0.5% on fiscal 2024 ($524M).
How fast has Core Laboratories Inc.'s revenue grown?
From $470M in fiscal 2021 to $527M in fiscal 2025: a compound annual growth rate of +2.9% over 4 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Where these figures come from
The SEC’s companyfacts data: every figure Core Laboratories Inc. tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
